Guidelines for DNA hybrid molecules.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Science

• Publication date

  1973-09-21

• Fields of study

  Biology, Medicine, Chemistry, Political Science

• Identifiers
  DOI 10.1126/SCIENCE.181.4105.1114PMID 11663279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Principles of behavioral analysis

  1967cited by this paper

• Money and murder: the dark side of the Asilomar meeting on recombinant DNA

  2025cites this paper
• Asilomar, Gene Cloning’s Origins, and Its Commercial Fate

  2025cites this paper
• Shifting Values and Shifting Risks: Debates on the New Biology in Germany and the United States Before and After Asilomar (1960–1980)

  2025cites this paper
• Asilomar Across the Atlantic: EMBO, EMBL, and the Politics of Scientific Expertise

  2025cites this paper
• „Die ungeklärten Gefahrenpotentiale der Gentechnologie“. Öffentliche Wissenschaft, Inszenierungsstrategien und Rhetorik der Objektivität im Kontext der bundesdeutschen Gentechnologie-Debatte

  2022cites this paper
• You can't keep a bad idea down: Dark history, death, and potential rebirth of eugenics

  2021cites this paper
• Scale-Down Models and Sensors for Process Development

  2020cites this paper
• Perfusion Bioreactors:The Set-Up and Process Characterisation

  2020cites this paper
• Perfusion Cell Culture Processes for Biopharmaceuticals

  2020cites this paper
• Perfusion Mammalian Cell Culture for Recombinant Protein Manufacturing

  2020cites this paper
• Index

  2020cites this paper
• Clinical- and Commercial-Scale Reactors

  2020cites this paper
• Mechanistic and Statistical Modelling of Bioprocesses

  2020cites this paper
• Design and Optimisation of Mammalian Cell Perfusion Cultures

  2020cites this paper
• From Asilomar to Genome Editing: Research Ethics and Models of Decision

  2019cites this paper
• Designing Artificial Intelligence Review Boards: Creating Risk Metrics for Review of AI

  2019cites this paper
• Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications

  2018cites this paper
• Self-Regulation of Science: What Can We Still Learn from Asilomar?

  2017cites this paper
• Sustainable Innovation in Food Science and Engineering

  2016cites this paper
• Innovative farmers and regulatory gatekeepers: Genetically modified crops regulation and adoption in developing countries.

  2016cites this paper
• Bioethics and Climate Change: A Response to Macpherson and Valles.

  2016cites this paper
• The Innovation and Diffusion of Policy: Novelty in the Canadian Regulatory System for Plants with Novel Traits

  2015cites this paper
• Genomic misconception: a fresh look at the biosafety of transgenic and conventional crops. A plea for a process agnostic regulation.

  2014cites this paper
• Asilomar moments: formative framings in recombinant DNA and solar climate engineering research

  2014cites this paper
• HERBERT BOYER AND STANLEY COHEN: RECOMBINANT DNA

  2014cites this paper
• Trends in United States Biological Materials Oversight and Institutional Biosafety Committees.

  2014influential citation
• DNA cloning: A personal view after 40 years

  2013cites this paper
• Regulatory issues of biotechnologically improved plants

  2012cites this paper
• European attitudes on the regulation of modern biotechnology and their consequences.

  2012cites this paper
• Ferretting out the facts behind the H5N1 controversy

  2012cites this paper
• Adaptations of Avian Flu Virus Are a Cause for Concern

  2012cites this paper
• Biomedical Advances Confront Society: Congressional Hearings and the Development of Bioethics, 1960-1975

  2012cites this paper
• International vergleichende Analyse und Bewertung der Konzepte zur GVO-Risikoanalyse

  2012cites this paper
• Policy: Adaptations of avian flu virus are a cause for concern

  2012cites this paper
• Systemic risks of genetically modified crops : the need for new approaches to risk assessment

  2011cites this paper
• Systemic risks of genetically modified crops: the need for new approaches to risk assessment

  2011cites this paper
• Personal Reflections on the Origins and Emergence of Recombinant DNA Technology

  2010cites this paper
• thérapie génique au Royaume-Uni : enjeux et controverses

  2009cites this paper
• Gene Therapy Oversight: Lessons for Nanobiotechnology

  2009cites this paper
• Genetic engineering in agriculture: New approaches for risk management through sustainability reporting

  2008cites this paper
• Reverse-FOIA limitations on agency actions to disclose human gene therapy clinical trial data.

  2008cites this paper
• Conceptual approaches to manage the cultivation of genetically modified plants

  2008cites this paper
• Don't Blame Me—I'm Just a Cell Biologist

  2008cites this paper
• Moments of discovery.

  2008cites this paper
• Ethics in the Societal Debate on Genetically Modified Organisms: A (Re)Quest for Sense and Sensibility

  2006cites this paper
• The Budapest meeting 2005 intensified networking on ethics of science

  2006cites this paper
• How should public policy respond to the challenges of modern biotechnology?

  2004cites this paper
• Recombinant DNA, Policy, Asilomar Conference

  2002cites this paper
• The Regulation of Modern Biotechnology: A Historical and European Perspective: A Case Study in How Societies Cope with New Knowledge in the Last Quarter of the Twentieth Century

  2001influential citation
• Controlling Biological Warfare Threats: Resolving Potential Tensions among the Research Community, Industry, and the National Security Community

  2001cites this paper
• Case Studies in Benefits and Risks of Agricultural Biotechnology: Roundup Ready Soybeans and Bt Field Corn

  2001cites this paper
• Drawing the Line in Genetic Engineering: Self-Regulation and Public Participation

  2001cites this paper
• Biosafety in rDNA Research and Production

  2001cites this paper
• From pesticides to genetically modified plants: history, economics and politics

  2000cites this paper
• Actor-networks, international political economy and risk in genetic manipulation

  1999cites this paper
• Die Steuerung der Freisetzungsregulierung durch das US-amerikanische Verfassungsrecht

  1998cites this paper
• Computational fluid dynamics as a tool for quantitative biosafety studies.

  1998cites this paper
• Learning from history

  1997cites this paper
• The Recombinant DNA Controversy: Twenty Years Later

  1995cites this paper
• The recombinant DNA controversy: twenty years later.

  1995cites this paper
• 2 – RECOMBINANT DNA CLONING

  1995cites this paper
• The public as a partner at the laboratory bench.

  1994cites this paper
• Administration at the Cusp of Science

  1992cites this paper
• Categories of large-scale containment for manufacturing processes with recombinant organisms.

  1989cites this paper
• [Safety problems in biotechnology. Medical biotechnology and safety].

  1987cites this paper
• Controlling the bugs

  1985cites this paper
• The management and assessment of risks from recombinant organisms

  1985cites this paper
• Development of the National Institutes of Health Guidelines for Recombinant DNA Research.

  1983cites this paper
• Biotechnology and the lawmakers.

  1983cites this paper
• Biohazards due to Microorganisms

  1982cites this paper
• Recombinant DNA and Responsible Intervention

  1982cites this paper
• In pursuit of safety.

  1981cites this paper
• Identifying biohazards in university research.

  1980cites this paper
• Recombinant DNA research: the scope and limits of regulation.

  1979cites this paper
• Much Ado about Recombinant DNA Regulations

  1978cites this paper
• Common sense in genetic engineering.

  1978cites this paper
• The little beasts

  1978cites this paper
• Position paper of the AFCR Public Policy Committee: recombinant DNA research.

  1978cites this paper
• Recombinant DNA research.

  1978cites this paper
• Genetic intervention: the modern chimera.

  1977cites this paper
• Recombinant DNA: NIH Guidelines.

  1976cites this paper
• Reflections on issues posed by recombinant DNA molecule technology. I.

  1976cites this paper
• REFLECTIONS ON ISSUES POSED BY RECOMBINANT DNA MOLECULE TECHNOLOGY. I

  1976cites this paper
• Genetic manipulation of microorganisms: potential benefits and biohazards.

  1976cites this paper
• Costs and benefits of recombinant DNA research.

  1976cites this paper
• Restriction endonucleases in the analysis and restructuring of dna molecules.

  1975cites this paper
• Recent advances in microbial genetics.

  1975cites this paper
• Potential biohazards of recombinant DNA molecules.

  1974cites this paper
• Potential biohazards of recombinant DNA molecules.

  1974cites this paper
• Notes of a biology-watcher. On etymons and hybrids.

  1974cites this paper
• Editorial: Advances in molecular genetics.

  1973cites this paper